BPA Call HT941024A0007-HT941026FE011
Award Date 12/15/25
Potential Completion Date 12/19/25
Potential Value $11K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Japan
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Health Agency awarded a $41,425.96 firm fixed-price blanket purchase agreement call to Ortho Clinical Diagnostics K.K. for chemistry and immunoassay testing system reagents and supplies, with an ultimate completion date of September 22, 2025. The contract, which carries no socioeconomic set-aside designation, supports laboratory diagnostic operations at U.S. military medical facilities throughout Japan. Ortho Clinical Diagnostics K.K., a Japanese subsidiary of the global in vitro...
- The Defense Health Agency awarded a $18,146.59 firm fixed-price blanket purchase agreement call to Ortho Clinical Diagnostics K.K., a Japanese subsidiary of the global in vitro diagnostic solutions provider, for chemistry and immunoassay testing system reagents and supplies. The contract, with an ultimate completion date of November 17, 2025, was awarded without set-aside designation and will be performed in Japan. This call draws from Ortho Clinical Diagnostics K.K.'s existing $2.875M...
- The Defense Health Agency awarded a $29,492.53 firm fixed-price Blanket Purchase Agreement (BPA) call to Ortho Clinical Diagnostics K.K. on March 14, 2025, for chemistry and immunoassay testing system reagents and consumable supplies. The contract, which carries an ultimate completion date of April 1, 2025, will be performed in Japan and supports U.S. military medical operations in the Indo-Pacific region. This award was not set aside for any socioeconomic category and represents a call...
- The Defense Health Agency awarded a $17,926.76 firm fixed-price BPA call to Ortho Clinical Diagnostics K.K. on February 24, 2025, with an ultimate completion date of March 3, 2025. The contract covers Chemistry and Immunoassay Testing System (VITROS and VITROS 7600) reagents and consumable supplies to be delivered to Japan. This award was not made under a socioeconomic set-aside program and represents a delivery order against the vendor's existing blanket purchase agreement with the Defense...
- The Defense Health Agency awarded a $14,025.72 firm fixed-price Blanket Purchase Agreement call to Ortho Clinical Diagnostics K.K. on September 25, 2025, for chemistry and immunoassay testing system reagents and supplies. The contract was not designated under any socioeconomic set-aside program and carries an ultimate completion date of October 10, 2025. The work will be performed in Japan, where the vendor operates as a subsidiary of the global in vitro diagnostic solutions provider Ortho...
- The Defense Health Agency awarded a $30,041.39 firm fixed-price Blanket Purchase Agreement (BPA) call to Ortho Clinical Diagnostics K.K. on July 25, 2025, for chemistry and immunoassay testing system reagents and supplies, with a completion date of September 30, 2025. The work will be performed in Japan and supports critical laboratory diagnostic operations at U.S. military medical facilities throughout the Indo-Pacific region. This call order is issued under the vendor's existing $2.875 million...
- The Defense Health Agency awarded a $24,248.52 firm fixed-price call under an existing Blanket Purchase Agreement to Ortho Clinical Diagnostics K.K. for chemistry immunoassay testing system reagents and supplies. The contract, effective July 15, 2025, with an ultimate completion date of July 15, 2025, will be performed in Japan. This procurement supports the supply of VITROS laboratory reagents and consumable diagnostic testing supplies to U.S. military medical facilities across the Indo-Pacific...
- The Defense Health Agency awarded a $20,818.99 firm fixed-price Blanket Purchase Agreement call to Ortho Clinical Diagnostics K.K. on June 27, 2025, for chemistry immunoassay testing system reagents and supplies. The contract will be performed in Japan with an ultimate completion date of July 15, 2025. This call order leverages a larger indefinite-delivery vehicle—a $875,000 Blanket Purchase Agreement with the Defense Health Agency effective through June 2029—which enables the procurement of...
- The Defense Health Agency awarded a $31,718.44 firm fixed-price BPA call to Ortho Clinical Diagnostics K.K., a Japanese subsidiary of the global diagnostic solutions provider Ortho Clinical Diagnostics, with a completion date of September 30, 2025. This contract supports the procurement of chemistry and immunoassay testing system reagents and supplies, which are essential consumable materials for VITROS laboratory diagnostic equipment used across U.S. military medical facilities in Japan. The...
- The Defense Health Agency awarded a $69,648.26 firm fixed-price Blanket Purchase Agreement (BPA) call to Ortho Clinical Diagnostics K.K. on July 28, 2025, for chemistry and immunoassay testing system reagents and supplies. The contract will be performed in Japan with an ultimate completion date of September 30, 2025. Ortho Clinical Diagnostics K.K. is a Japanese subsidiary of Ortho Clinical Diagnostics, a global provider of in vitro diagnostic solutions, and specializes in supplying VITROS...